Variant report
Variant | esv3377317 |
---|---|
Chromosome Location | chr1:73236664-73240162 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556187385 | chr1:73236693-73236694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2692855 | chr1:73236706-73236707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544938795 | chr1:73236721-73236722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564849638 | chr1:73236782-73236783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572176141 | chr1:73236783-73236784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540868479 | chr1:73236790-73236791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6672077 | chr1:73236812-73236813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2841187 | chr1:73236826-73236827 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs549800001 | chr1:73236853-73236854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187083932 | chr1:73236894-73236895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532025803 | chr1:73236935-73236936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552076500 | chr1:73236952-73236953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571852275 | chr1:73236966-73236967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116696765 | chr1:73236972-73236973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78781551 | chr1:73236976-73236977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567748147 | chr1:73236977-73236978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536377461 | chr1:73237000-73237001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556124047 | chr1:73237036-73237037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575996111 | chr1:73237041-73237042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1358040 | chr1:73237060-73237061 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs541765407 | chr1:73237067-73237068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368558191 | chr1:73237165-73237166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558767766 | chr1:73237170-73237171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572256743 | chr1:73237171-73237172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541207429 | chr1:73237234-73237235 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535387316 | chr1:73237264-73237265 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560970843 | chr1:73237298-73237299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs61771931 | chr1:73237338-73237339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541242245 | chr1:73237369-73237370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76215393 | chr1:73237415-73237416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563386734 | chr1:73237428-73237429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532099587 | chr1:73237435-73237436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183287502 | chr1:73237444-73237445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188629207 | chr1:73237451-73237452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528025289 | chr1:73237470-73237471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547951541 | chr1:73237480-73237481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115914056 | chr1:73237481-73237482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143509395 | chr1:73237568-73237569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115809323 | chr1:73237580-73237581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569816210 | chr1:73237606-73237607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538605486 | chr1:73237654-73237655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558719335 | chr1:73237696-73237697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565961468 | chr1:73237719-73237720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114452277 | chr1:73237874-73237875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554732458 | chr1:73237880-73237881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1525986 | chr1:73237902-73237903 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs147174233 | chr1:73237936-73237937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192297276 | chr1:73237967-73237968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78622792 | chr1:73237969-73237970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577052940 | chr1:73237974-73237975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:73236600-73237200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:73236600-73237400 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr1:73236800-73237400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr1:73237200-73242400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |